What Reduces Prostate Cancer Risk: Diet, Exercise & More

Several factors can meaningfully reduce your risk of prostate cancer, ranging from specific foods to exercise habits to maintaining a healthy weight. The strongest evidence points to a combination of dietary choices rich in certain plant compounds, regular vigorous physical activity, and avoiding a few surprising risk factors like excessive calcium intake. Some medications also lower risk, though they come with trade-offs worth understanding.

Lycopene-Rich Foods Show Strong Protection

Lycopene, the pigment that gives tomatoes and watermelon their red color, is one of the most studied dietary factors in prostate cancer prevention. In a prospective cohort study published in BMC Medicine, men with the highest lycopene intake had a 54% lower risk of prostate cancer compared to those who ate the least. The protective effect kicked in at intakes above about 4.9 mg per day, where the risk dropped by 64%.

That threshold is surprisingly easy to hit. About 175 grams of tomato (roughly one large tomato) or 110 grams of watermelon per day gets you there. Cooked tomatoes, tomato sauce, and tomato paste are especially good sources because heat and processing make lycopene easier for your body to absorb. Adding a little fat, like olive oil in a pasta sauce, improves absorption further.

Cruciferous Vegetables and Coffee

Broccoli, cauliflower, Brussels sprouts, kale, and cabbage contain compounds that work against prostate cancer through multiple pathways. These vegetables produce substances that help your body’s detoxification systems clear potential carcinogens and also interfere with the signaling pathways that prostate cancer cells rely on to grow and spread. More recent research suggests these compounds can even alter gene expression in prostate cells in ways that suppress tumor development.

Coffee is another dietary factor with convincing evidence behind it. In a large study of nearly 48,000 men tracked over two decades through the Health Professionals Follow-up Study, those who drank six or more cups per day had an 18% lower risk of prostate cancer overall. The effect was far more dramatic for the most dangerous forms: heavy coffee drinkers had a 60% lower risk of lethal prostate cancer. Both caffeinated and decaffeinated coffee showed similar benefits, suggesting the protective effect comes from other compounds in coffee, including chlorogenic acids and lignans, which influence antioxidant activity and how the body handles insulin and glucose.

Exercise Cuts Risk Substantially

Physical activity is one of the most powerful modifiable factors for prostate cancer outcomes. A study published in the Journal of Clinical Oncology found that men who engaged in three or more hours of vigorous activity per week had a 61% lower risk of dying from prostate cancer compared to men who did less than one hour per week. Their overall mortality risk dropped by 49%.

Vigorous activity means exercise intense enough that you’re breathing hard and sweating: running, cycling, swimming laps, or playing competitive sports. Walking and lighter activity have benefits too, but the strongest risk reductions are tied to higher-intensity exercise. The mechanism likely involves exercise’s broad effects on hormone levels, inflammation, insulin sensitivity, and immune function.

Body Weight and Aggressive Disease

The relationship between obesity and prostate cancer is more nuanced than you might expect. Carrying excess weight may slightly reduce your chance of being diagnosed with a slow-growing, localized tumor. But it significantly increases your risk of the cancers you actually need to worry about: aggressive, advanced, and fatal prostate cancers. A meta-analysis of multiple prospective studies confirmed this pattern.

Obesity also worsens outcomes after diagnosis. Men who are obese at the time of treatment face higher rates of treatment failure, more complications, and greater prostate cancer-specific mortality. Maintaining a healthy weight through the dietary and exercise habits described above addresses multiple risk factors simultaneously.

Watch Your Calcium Intake

This one catches many people off guard. High calcium intake, particularly above 2,000 mg per day, is associated with a 24% increased risk of prostate cancer overall, with stronger links to lethal and high-grade tumors. In the Health Professionals Follow-up Study, intakes above 1,500 mg per day were already linked to higher risk of advanced and fatal cancers, and the elevated risk appeared to develop over a 12- to 16-year window after exposure.

This doesn’t mean you should avoid calcium entirely. Your bones need it. But men who take calcium supplements on top of a dairy-heavy diet could easily exceed 2,000 mg per day. If you’re supplementing calcium, it’s worth reviewing whether you actually need to be.

Skip Vitamin E and Selenium Supplements

For years, vitamin E and selenium were touted as prostate cancer prevention supplements based on early, suggestive findings. The SELECT trial, a large National Cancer Institute study, put that idea to rest definitively. Not only did selenium supplements fail to reduce prostate cancer risk, but men who took vitamin E alone had a 17% increase in prostate cancer diagnoses compared to men on placebo. That increase was statistically significant.

The earlier positive findings for selenium may have applied only to men who were deficient in selenium to begin with, not to the general population. The broader lesson is that isolated supplements rarely replicate the benefits of whole foods, and they can sometimes cause harm. Getting these nutrients from food, where they exist alongside hundreds of other compounds, appears to be both safer and more effective.

Medications That Lower Risk

A class of medications originally developed for enlarged prostates has shown a clear cancer prevention effect. In the Prostate Cancer Prevention Trial, men taking finasteride developed 30% fewer prostate cancers than men on placebo over an average of seven years: 10.5% versus 14.9%. The reduction came entirely from fewer low-grade, slow-growing tumors.

Neither finasteride nor the related drug dutasteride is FDA-approved specifically for cancer prevention, but men already taking these medications for urinary symptoms related to an enlarged prostate get a secondary benefit. The decision to take them purely for cancer prevention involves weighing side effects like reduced libido against the risk reduction, which is a conversation shaped by your individual risk profile.

The Role of PSA Screening

Screening doesn’t prevent prostate cancer from developing, but it can catch dangerous cancers early enough to treat them before they spread. The U.S. Preventive Services Task Force recommends that men aged 55 to 69 make an individual decision about PSA testing after discussing the benefits and harms with their doctor. Men 70 and older are generally not recommended for routine screening.

The benefits and harms are real on both sides. Screening can identify high-risk cancers that would otherwise go undetected until they’ve spread. But it also detects many slow-growing cancers that would never cause symptoms or shorten life, potentially leading to unnecessary biopsies and treatments with side effects like incontinence or sexual dysfunction. For men with additional risk factors, such as a family history of prostate cancer or Black race, the balance tends to tip more clearly toward screening.